P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors

MLA

B. De La Puente, et al. “P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors.” Journal of Thoracic Oncology, vol. 16, Oct. 2021, pp. S1074–75. EBSCOhost, https://doi.org/10.1016/j.jtho.2021.08.449.

APA

B. De La Puente, C. Traseira, M. Martínez-Cutillas, R. Aguado, Y. Garitaonaindia, V. Calvo, M. Provencio, A. Collazo-Lorduy, G. Visedo, M. Torrente, M. Blanco Clemente, A. Morito, & F. Franco. (2021). P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors. Journal of Thoracic Oncology, 16, S1074–S1075. https://doi.org/10.1016/j.jtho.2021.08.449

Chicago

B. De La Puente, C. Traseira, M. Martínez-Cutillas, R. Aguado, Y. Garitaonaindia, V. Calvo, M. Provencio, et al. 2021. “P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors.” Journal of Thoracic Oncology 16 (October): S1074–75. doi:10.1016/j.jtho.2021.08.449.